Pokemon reduces Bcl-2 expression through NF-κ Bp65: A possible mechanism of hepatocellular carcinoma

Asian Pacific Journal of Tropical Medicine

Volumn 4, Issue 6, 2011, Pages 492-497

  Zhao, Xinkai ^a,b   Ning, Qiaoming ^b   Sun, Xiaoning ^b   Tian, De'an ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Bcl 2; Hepatocellular carcinoma; NF B p65; Pokemon

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; ONCOPROTEIN; POKEMON; PROTEIN BCL 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; POKEMON GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 79960268371     PISSN: 19957645     EISSN: 19957645     Source Type: Journal    
DOI: 10.1016/S1995-7645(11)60133-8     Document Type: Article

References (28)

1. Maeda T, Hobbs RM, Pandolfi PP The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 2005, 65(19):8575-8578.
2. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005, 433(7023):278-285.
3. Apostolopoulou K, Pateras IS, Evangelou K, Tsantoulis PK, Liontos M, Kittas C, et al. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 2007, 213:294-302.
4. Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, et al. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance. Chinese Medical J 2008, 121:445-449.
5. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH, Evans RM Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998, 391:811-814.
6. Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, Bardwell V, et al. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol 2002, 22:1804-1818.
7. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, Elsässer HP, et al. Miz1 is required for early embryonic development during gastrulation. Mol Cell Biol 2003, 23:7648-7657.
8. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, et al. Heterozygous disruption of Hic1 predisposes mice to a gender dependent spectrum of malignant tumors. Nature Genet 2003, 33:197-202.
9. Agrawal A, Yang J, Murphy RF, Agrawal DK Regulation of the P14ARF-Mdm2-P53 pathway: an overview in breast cancer. Exp Mol Pathol 2006, 81(2):115-122.
10. Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, Bardwell V, et al. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol 2002, 22:1804-1818.
11. Stogios PJ, Downs GS, Jauhal JJ, Nandra SK, Privé GG Sequence and struetural analysis of BTB domain proteins. Genome Biol 2005, 6(10):203-221.
12. Stogios PJ, Chen L, Privé GG Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator. Protein Sci 2007, 16(2):336-342.
13. Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, Brand NJ, et al. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/Bcl-6 oncogene. Oncogene 2001, 18:365-375.
14. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-κ B functions as a tumor promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
15. Wang T, Wang Y, Wu MC, Guan XY, Yin ZF Activating mechanism of transcriptor NF-kappa B regulated by hepatitis B virus X protein in hepatocellular carcinoma. World J Gastroenterol 2004, 10:356-360.
16. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besançon F, Bauvy C, Souquère S, et al. NF-kappa bactivation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 2006, 281(41):30373-30382.
17. Beerheide W, Tan YJ, Teng E, Ting AE, Jedpiyawongse A, Srivatanakul P Down regulation of preopoplotic proteins bax and Bcl-X(S) in p53 overexpressing hepatocellular cancinomas. Biochem Biophys Res Commum 2000, 273(1):54-61.
18. Elsharkawy AM, Mann DA Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 2007, 46:590-597.
19. Yague E, Armesilla AL, Harrison G, Elliott J, Sardini A, Higgins CF, et al. P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem 2003, 278(12):10344-10352.
20. Livak KJ, Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta CT) method. Methods 2001, 25(4):402-408.
21. Pinkenburg O, Platz J, Beisswenger C, Vogelmeier C, Bals R Inhibition of NF-κ B mediated inflammation by siRNA expressed by recombinant adeno-associated virus. J Virol Methods 2004, 120(1):119-122.
22. Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activato, and HBx and their clinicopathological significance in hepato-cellular carcinoma. Clin Cancer Res 2004, 10(12 Pt 1):4140-4149.
23. Shishodia S, Aggarwal BB Nuclear factor-kappaB: a friend or a foe in cancer. Bio Chem Pharmacol 2004, 68(6):1071-1080.
24. Perkins ND, Gilmore TD Good cop, bad cop: the different faces of NF-kappa B. Cell Death Differ 2006, 13(5):759-772.
25. Wang J, Huang Q, Chen M The role of NF-kappaB in hepatocellular carcinoma cell. Chin Med J (Engl) 2003, 116(5):747-752.
26. Lee DK, Kang JE, Park HJ, Kim MH, Yim TH, Kim JM, et al. FBI-I enhances transcription of the nuclear factor-κ B (NF-κ B) responsive E-selectin gene by nuclear localization of the p65 subunit of NF-κ B. J Biol Chem 2005, 280(30):277-283.
27. Arsura M, Cavin LG Nuclear factor-kappa B and liver carcinogenesis. Cancer Lett 2005, 229(2):157-169.
28. Herman MD, Nyman T, Welin M, Lehtiö L, Flodin S, Trésaugues L, Kotenyova T, et al. Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-l in complex with Bim. FEBS Lett 2008, 582(25-26):3590-3594.